GenomeWeb takes note of GeneKey

This recent GenomeWeb article does a fine job of explaining our services and how we are different from other genomic, personalized oncology products currently on the market. Key points include how GeneKey takes a systems biology approach to gain insight into how a patient's tumor cells are different from his or her normal cells. These biological differences are not limited to mechanisms that drive tumor growth but may potentially expose how the tumor is keeping itself alive. We then apply this information to identify additional drugs that might be considered. The article notes that another unique aspect of GeneKey's services is "deep, in-person consultation with a patient's physician; and ongoing support for therapeutic decision making."

Read more:  

GeneKey Sees Breadth of Cancer Genome Advisory Service as Differentiator in Rapidly Growing Market